Research location
Hwasun
Jeollanam-do, South Korea
Advertisement
Research activity in Hwasun
Jeollanam-do, South KoreaCureCurrent currently publishes aggregate city-level research activity for this location: 19 trials and 19 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Hwasun
19 linked trials · page 1 of 1Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon MutationsNCT07185997 · 2025-12-17 · 1 site observation
RECRUITING
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF AlterationsNCT05503797 · 2023-02-21 · 1 site observation
RECRUITING
A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-Small Cell Lung Cancer That Can be Treated With SurgeryNCT06161441 · 2024-07-16 · 1 site observation
ACTIVE_NOT_RECRUITING
Observational Study of Triple Combination Therapy of Zemidapa Tab. and Metformin in Type 2 Diabetes Mellitus PatientsNCT06495281 · 2023-10-26 · 1 site observation
COMPLETED
A Trial to Learn How the Cancer Vaccine BNT116 in Combination With Cemiplimab Works and How Safe the Combination is in Adults With Advanced Non-small Cell Lung Cancer (EMPOWERVAX Lung 1)NCT05557591 · 2023-04-21 · 1 site observation
ACTIVE_NOT_RECRUITING
G7 Dual Mobility With Vivacit-E or Longevity PMCFNCT05548972 · 2023-03-20 · 1 site observation
ENROLLING_BY_INVITATION
Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPCNCT04446117 · 2020-10-19 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor (MET)-Altered Advanced Non-Small Cell Lung CancerNCT04077099 · 2020-01-07 · 1 site observation
ACTIVE_NOT_RECRUITING
Evaluation of Blood TMB for the Efficacy of Atezolizumab [BUDDY]NCT04059887 · 2019-12-18 · 1 site observation
COMPLETED
Retreatment With Epidermal Growth Factor Receptor(EGFR) Tyrosine Kinase Inhibitor in EGFR Mutation Positive PatientsNCT03382795 · 2018-01-03 · 1 site observation
UNKNOWN
Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302)NCT03260894 · 2017-12-07 · 1 site observation
COMPLETED
Prospective Cohort Study Depending on the Use of Palliative Care for Advanced Stage of Cancer PatientsNCT03222258 · 2016-12-17 · 1 site observation
COMPLETED
Osimertinib in First and Second Line Treatment of NSCLC Harboring EGFR Mutations From Circulating Tumor DNANCT02769286 · 2016-08-01 · 1 site observation
COMPLETED
Afatinib in Lung Cancer With EGFR Mutation From Circulating Tumor DNANCT02629523 · 2016-06-01 · 1 site observation
COMPLETED
Efficacy and Safety of Adjuvant Pemetrexed Plus Cisplatin for Adenocarcinoma of LungNCT02498860 · 2015-09-01 · 1 site observation
COMPLETED
Safety and Efficacy of Donepezil HCl 23 mg in Patients With Moderate to Severe Alzheimer's DiseaseNCT02097056 · 2014-02-01 · 1 site observation
COMPLETED
TaxoteRe Plus Cisplatin Versus AlImta Plus Cisplatin in 1st Line Non-squamous Cell Type Lung CancerNCT01282151 · 2011-07-01 · 1 site observation
TERMINATED
A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung CancerNCT01362400 · 2011-05-01 · 1 site observation
COMPLETED
BELotaxel(Docetaxel) and bellOXa(Oxaliplatin) in Advanced NSCLCNCT01243775 · 2010-11-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.